%0 Journal Article %K Aged %K Analgesics, Opioid/adverse effects %K Codeine/adverse effects %K *Hip Fractures/chemically induced/drug therapy/epidemiology %K Humans %K Pain/drug therapy %K Quality of Life %K *Tramadol/adverse effects %B Drug Saf %D 2022 %G eng %M 35810265 %P 791-807 %R 10.1007/s40264-022-01198-9 %T Hip Fracture Risk After Treatment with Tramadol or Codeine: An Observational Study %V 45 %2 PMC9296392 of Janssen Research and Development LLC and shareholders of Johnson & Johnson (J&J) stock. Daniel Fife, at the time of this research, was also an employee Janssen Research and Development LLC and shareholder of J&J stock; however, he has since retired. Peter R. Rijnbeek is an employee of an institution that receives/received research grants from Janssen Research and Development LLC. J&J subsidiary companies market both tramadol-containing and codeine-containing products. %7 2022/07/10 %@ 0114-5916 (Print) 0114-5916